Keep Current with the Latest in Cell Biology Research
Block title
FDA Approves Cabozantinib for Adults and Pediatric Patients 12 Years of Age and Older with pNET and epNET
[FDA] The FDA approved cabozantinib for adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated pancreatic neuroendocrine tumors (pNET) and well-differentiated extra-pancreatic neuroendocrine tumors (epNET).
Spermidine Restricts Neonatal Inflammation via Metabolic Shaping of Polymorphonuclear Myeloid-Derived Suppressor Cells
[Journal of Clinical Investigation] Scientists reported that plasma spermidine was correlated with the maturity of human newborns and reduced risk of inflammation. Administration of spermidine led to the remission of neonatal inflammation in mice.
Enhancing Anti-CD3 mAb-Mediated Diabetes Remission in Autoimmune Diabetes through Regulation of Dynamin-Related Protein 1(Drp1)-mediated Mitochondrial Dynamics in Exhausted CD8+T-Cell Subpopulations
[BMC Medicine] The phenotypic and metabolic properties of two subsets of exhausted CD8+ T cells were analyzed in both humans and NOD mice. T-cell receptor (TCR) diversity and Bulk RNA sequencing provided insights into the transcriptomic profiles and TCR reactivity of these cells.
Immune Evasion Mechanisms in Early-Stage I High-Grade Serous Ovarian Carcinoma: Insights into Regulatory T Cell Dynamics
[Cell Death & Disease] Researchers performed single-cell RNA-sequencing analysis and revealed a highly immunosuppressive high-grade serous ovarian carcinoma microenvironment, characterized by abundant infiltration of Tregs.
Neoantigen-Specific Tumor-Infiltrating Lymphocytes in Gastrointestinal Cancers: A Phase II Trial
[Nature Medicine] In an evolving single-arm Phase II trial design, tumor-infiltrating lymphocytes were derived from and administered to 91 patients with treatment-refractory mismatch repair proficient metastatic gastrointestinal cancers in a schema with lymphodepleting chemotherapy and high-dose interleukin-2.
Multilayered HIV-1 Resistance in HSPCs through CCR5 Knockout and B Cell Secretion of HIV-Inhibiting Antibodies
[Nature Communications] The authors proposed a one-time therapy through autologous transplantation of hematopoietic stem and progenitor cells genetically engineered ex vivo to produce both CCR5 knockout cells and long-term secretion of potent HIV-1 inhibiting antibodies from B cell progeny.
Hantaan Virus Infection Induces Human Mucosal-Associated Invariant T Cell Pyroptosis through IRE1α Pathway
[Communications Biology] By combining the clinical samples, mucosal-associated invariant T (MAIT) deficiency mice and in vitro infected MAIT cell models, scientists found that pyroptosis was the main reason of MAIT cell loss in the peripheral blood of hemorrhagic fever with renal syndrome patients.
Generation and Characterization of Neutralizing Antibodies against M1R and B6R Proteins of Monkeypox Virus
[Nature Communications] A panel of human antibodies targeting M1R and B6R was isolated from a human antibody library using phage display technology.
A New Era of Cancer Immunotherapy: Vaccines and miRNAs
[Cancer Immunology Immunotherapy] Investigators examine the important role of vaccines in cancer therapy, focusing on recent advancements such as dendritic cell vaccines, mRNA vaccines, and viral vector-based approaches.
Professor Laura Mackay Honoured by NHMRC for Leadership in Immunology and Medical Research
[The Doherty Institute] University of Melbourne’s Professor Laura Mackay has been presented with the National Health and Medical Research Council (NHMRC) Elizabeth Blackburn Investigator Grant Award for being the highest-ranking female applicant to receive an NHMRC Investigator Grant.
Lysyl Hydroxylase 2 Glucosylates Collagen VI to Drive Lung Cancer Progression
[Journal of Clinical Investigation] Researchers showed that a galactosylhydroxylysyl glucosyltransferase domain on lysyl hydroxylase 2-modified type-VI collagen to promote LUAD growth and metastasis.
Tumor Cell Heterogeneity Drives Spatial Organization of the Intratumoral Immune Response
[Journal of Experimental Medicine] The authors modeled heterogeneous tumors comprised of “hot” and “cold” tumor populations, giving rise to T cell–rich and T cell–poor tumors, respectively, and introduced fluorescent labels to enable precise spatial tracking.